The FY2025 (May) proxy of Lifecore Biomedical, Inc. \de\ names 22 peer companies for pay. Among Lifecore Biomedical, Inc. \de\ and these peers, CEO pay was the lowest of 7 and total shareholder return was 4th highest of 7.
7th highest of 7in Lifecore Biomedical, Inc. \de\ and its pay peers, FY2025 (May) by CEO pay:
$1.1M$6.9M
4th highest of 7in Lifecore Biomedical, Inc. \de\ and its pay peers, FY2025 (May) by total shareholder return:
$19$402
Pay peer group, FY2025 (May) proxy
| Artivion | ||
| Regenxbio | ||
| Cerus | ||
| Personalis | ||
| Aclaris Therapeutics | ||
| Codexis | ||
| ANI Pharma | Not disclosed | Not disclosed |
| Anika Thera | Not disclosed | Not disclosed |
| Avid Bioservices | Not disclosed | Not disclosed |
| ChromaDex | Not disclosed | Not disclosed |
| DLH Holdings | Not disclosed | Not disclosed |
| Harvard Bioscience | Not disclosed | Not disclosed |
| Infu System | Not disclosed | Not disclosed |
| Inotiv | Not disclosed | Not disclosed |
| Natural Alternatives International | Not disclosed | Not disclosed |
| OraSure Tech | Not disclosed | Not disclosed |
| ProPhase Labs | Not disclosed | Not disclosed |
| Societal CDMO | Not disclosed | Not disclosed |
| Standard Bio Tools | Not disclosed | Not disclosed |
| Surmodics | Not disclosed | Not disclosed |
| Sutro Biopharma | Not disclosed | Not disclosed |
| Xtant Medical | Not disclosed | Not disclosed |
%20{%20:root%20{%20filter:%20none;%20}%20}%20@media%20(prefers-color-scheme:%20dark)%20{%20:root%20{%20filter:%20none;%20}%20}%20%3c/style%3e%3c/svg%3e)
22 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.